Lameditech KRX:462510KOSDAQ

라메디텍 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked41since Sep 11

In Q2 2026, Lameditech reported revenue of ₩1.1bn, down 31.3% year on year, and an operating loss of ₩1.7bn. Lameditech (라메디텍) appeared in 0 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 19 with 8 articles. The most common catalyst was earnings (1). It was most often mentioned alongside T&R Biofab and SLSBio(Specialty Lab Solution Bio).

Filing signals 4 quarters of losses Screener

Lameditech quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩1.1bn-31.3%−₩1.7bn
margin −149.3%
−₩829m
Q1 2026₩815m-57.6%−₩2.8bn−₩2.9bn
Q4 2025 derived₩1.9bn-9.4%−₩3.4bn
margin −183.5%
−₩3.0bn
Q3 2025₩1.8bn+3.8%−₩3.0bn
margin −168.0%
−₩3.0bn
Q2 2025₩1.7bn-11.2%−₩2.6bn
margin −158.7%
−₩2.6bn
Q1 2025₩1.9bn+96.6%−₩2.9bn
margin −149.0%
−₩2.8bn
Q4 2024 derived₩2.0bn+107.1%−₩2.7bn
margin −131.1%
−₩2.8bn
Q3 2024₩1.7bn+345.1%−₩2.5bn
margin −147.4%
−₩2.3bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Lameditech top stories 2 weeks, by number of outlets

  1. 1
    라메디텍, hADM 기반 ECM 제품 '아이오필' 출시
    4 outlets · 4 articlesFirst report Oct 19 09:12 뉴시스경제
  2. 2
    ARC리서치 "라메디텍, 4분기 모멘텀 집중…실적 반등 가능성 주목"
    2 outlets · 2 articlesFirst report Oct 21 09:16 뉴시스경제
  3. 3
    라메디텍, 인체 유래 진피 소재 '아이오필' 출시…레이저 결합 시술 개발
    2 outlets · 2 articlesFirst report Oct 19 09:39 메디컬투데이
  4. 4
    라메디텍, 레이저 병합 시술 전략 소개…해외 유통 협력 확대
    2 outlets · 2 articlesFirst report Oct 20 13:35 메디파나뉴스
  5. 5
  6. 6
    라메디텍, 인체 유래 ECM ‘아이오필’ 출시
    1 outlets · 1 articlesFirst report Oct 20 10:36 의학신문(보사)

Latest Lameditech news Korean headlines